NEW YORK, July 20, 2024 (GLOBE NEWSWIRE) -- Top law firm Bleichmar Fonti & Auld LLP is investigating the R1 RCM Inc. (Nasdaq:RCM) acquisition by New Mountain Capital for $13.25 per share. Why is R1 RCM being Investigated by BFA Law? Shareholders are encouraged to submit your information to find out about your rights. Next Steps: All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court a ...

NEW YORK, July 16, 2024 (GLOBE NEWSWIRE) -- Top law firm Bleichmar Fonti & Auld LLP is investigating the R1 RCM Inc. (Nasdaq:RCM) acquisition by New Mountain Capital for $13.25 per share. Why is R1 RCM being Investigated by BFA Law? Shareholders are encouraged to submit your information to find out about your rights. Next Steps: All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court a ...

Why is R1 RCM being Investigated by BFA Law? Submit your information here: https://www.bfalaw.com/cases-investigations/r1-rcm-inc. All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses. To speak with an attorney for more information visit: Or contact: Ross Shikowitz ross@bfalaw.com 212-789-2303 NEW YORK, July 16, 2024 (GLOBE NEWSWIRE) -- T ...

NEW YORK, July 13, 2024 (GLOBE NEWSWIRE) -- Top law firm Bleichmar Fonti & Auld LLP is investigating the R1 RCM Inc. (NASDAQ:RCM) acquisition by New Mountain Capital for $13.25 per share. BFA is concerned that New Mountain Capital and TowerBrook, as well as members of R1 RCM's board of directors, may breach their fiduciary duties should they approve an unfair merger transaction for the benefit of New Mountain Capital and TowerBrook. If you currently own shares of R1 RCM, you may have legal options and are e ...

If you invested in R1 RCM, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/r1-rcm-inc. For more information about BFA and its attorneys, please visit https://www.bfalaw.com. If you currently own shares of R1 RCM, you may have legal options and are encouraged to contact the firm. NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Top law firm Bleichmar Fonti & Auld LLP is investigating the R1 RCM Inc. (NYSE:RCM) acquisition by New Mountain Capital for $13. ...

NEW YORK, July 11, 2024 (GLOBE NEWSWIRE) -- Top law firm Bleichmar Fonti & Auld LLP is investigating the R1 RCM Inc. (NYSE:RCM) acquisition by New Mountain Capital for $13.25 per share. Why is R1 RCM being Investigated by BFA Law? Shareholders are encouraged to submit your information to find out about your rights. Next Steps: https://www.bfalaw.com/cases-investigations/r1-rcm-inc If you invested in R1 RCM, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investig ...

NEW YORK, July 08, 2024 (GLOBE NEWSWIRE) -- Top law firm Bleichmar Fonti & Auld LLP is investigating the R1 RCM Inc. (NYSE:RCM) acquisition by New Mountain Capital for $13.25 per share. BFA is concerned that New Mountain Capital and TowerBrook, as well as members of R1 RCM's board of directors, may breach their fiduciary duties should they approve an unfair merger transaction for the benefit of New Mountain Capital and TowerBrook. All representation is on a contingency fee basis, there is no cost to you. Sh ...

MURRAY, Utah, June 17, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM) ("R1" or the "Company"), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today announced it will host a virtual event on Thursday, June 27, 2024 at 11:00 AM ET. To register, click here. A live audio webcast of this presentation will be available on the Investor Relations section of R1's website at r1rcm.com. A replay of the webcast will be availa ...

R1 is a leading provider of technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. R1's proven and scalable operating models seamlessly complement a healthcare organization's infrastructure, quickly driving sustainable improvements to net patient revenue and cash flows while reducing operating costs and enhancing the patient experience. To learn more, visit: r1rcm.com. Contacts Investor Relations: Evan Smith, CFA (516) 74 ...

Company Participants Evan Smith - Senior Vice President, Investor Relations Lee Rivas - Chief Executive Officer Jennifer Williams - Chief Financial Officer Thank you for standing by and welcome to the R1 RCM First Quarter 2024 Earnings Conference Call. [Operator Instructions] A reminder that this conference is also being recorded. I would now like to turn the conference over to Evan Smith, Senior Vice President, Investor Relations. Please go ahead. Thank you, operator and thank you everyone for joining us t ...